Abstract

T-LAK-cell-originated protein kinase (TOPK) is a PDZ-binding kinase (PBK) that was recently identified as a novel member of the mitogen-activated protein kinase (MAPK) family. It has been shown to play an important role in many cellular functions. However, its role in cardiac function remains unclear. Thus, we have herein explored the biological function of TOPK in myocardial ischemia/reperfusion (I/R) and oxidative stress injury in H9C2 cardiomyocytes. I/R and ischemic preconditioning (IPC) were induced in rats by 3-hour reperfusion after 30-min occlusion of the left anterior descending coronary artery and by 3 cycles of 5-min I/R. Hydrogen peroxide (H2O2) was used to induce oxidative stress in H9C2 cardiomyocytes. TOPK expression was analyzed by western blotting, RT-PCR, immunohistochemical staining, and immunofluorescence imaging studies. The effects of TOPK gene overexpression and its inhibition via its inhibitor HI-TOPK-032 on cell viability and Bcl-2, Bax, ERK1/2, and p-ERK1/2 protein expression were analyzed by MTS assay and western blotting, respectively. The results showed that IPC alleviated myocardial I/R injury and induced TOPK activation. Furthermore, H2O2 induced TOPK phosphorylation in a time-dependent manner. Interestingly, TOPK inhibition aggravated the H2O2-induced oxidative stress injury in myocardiocytes, whereas overexpression relieved it. In addition, the ERK pathway was positively regulated by TOPK signaling. In conclusion, our results indicate that TOPK might mediate a novel survival signal in myocardial I/R, and that its effect on anti-oxidative stress involves the ERK signaling pathway.

Highlights

  • In patients with acute myocardial infarction (AMI), the most effective treatment strategy for reducing myocardial ischemic injury is timely and effective myocardial reperfusion

  • We identified for the first time a function of T-LAK-cell-originated protein kinase (TOPK) protein in myocardial I/R and Inotxhiidsasttivuedsyt,rweses iidnjeunrtyifiinedcafrodriothmeyfiorcsyttetism

  • It has been shown that the cardioprotection by Ischemic preconditioning (IPC) is mediated by activation of survival signaling [23]

Read more

Summary

Introduction

In patients with acute myocardial infarction (AMI), the most effective treatment strategy for reducing myocardial ischemic injury is timely and effective myocardial reperfusion. The process of reperfusion can cause additional cardiomyocyte dysfunction and death, which is generally referred to as myocardial reperfusion injury [1]. Some progress has been made in the past decade in relation to understanding the mechanisms of ischemia/reperfusion (I/R) injury and finding strategies to address it; the protective effects of clinical therapeutic approaches seem limited [2]. Ischemic preconditioning (IPC) was first reported by Murry and associates [3] and has been exploited as a powerful endogenous mechanism. 2 of 14 2 of 14 powerful endogenous mechanism for cardioprotection against I/R injury. RIesvci1hv.eoIm.sci(hcAep)mreiRcceoppnrrdeeicstoieonnndtaiintigovn(eIiPnpCgh)(otIrtPoeCag)trmatrpeehnasttmdoeefcnrteEdavseaecndrsemasbyeloudcema-rTydToiCaclairsddcoihauelbmilseicah/setrmaeipinaei/rnrfgeupsieaornnfdu(sIi/tohRne)(I/R) iqnujuarnyitniitjnuatrviyviveoi.na(nAav)liyvRosei.sp(roAefs)emnRtyaeotpcivraeersdpeinhaotlatitonigvfarearcppthhssoioztfeoEgbrveaatpnwhsesbelnuofeI-/TRETv(Ca3n0d-smoubibnluleiess-cTthaTeinCminiadg/o3au-nhbdoletuhresrtqaeuipnaeinrnftguitsaitaoinvnde) the aannadlyIqPsuiCsano(tfhimtraetyeiovcceyacradlneiasallyoisfni5sfa-morcfitnmsiIzyseochcbaeermtdwiae/le5ni-nmIf/ainRrcR(t3es0pi-zmeerifnbuesitiswocnhe)ee+mnI/iRIa//Rg3r-(oh3u0op-umsr; ir(neBp)iseHcrhfeuemsmiaoitnao/)x3ay-nhlidonuIarPnCrde(petheorrsfeiunesion) c(HycEle)assnotdafi5nIP-imnCgin(tohIfsrcethheercmeyeicalg/ers5o-oumfpi5sn-,mRsheinpoewIrsifcnuhgseimoIPni)Ca+/5Im/-mRedigniraoRtueedppsea;rl(flBuev)siHoanteim)o+nIa/tRoofxgytrhloienupmansy;do(Becoa) rsHdineium(HmaEtod) xesytsatlriinnuicnatngiodonf;eosin t(hCr)ePe(oHgsrEiot)iuvpsetsan,iusnhcinolegwarionfsgttahIiPnreCinemggferoodruiamptsey,doscahalolrewdviiianaltgiaopInPoCpoftomthsieesdmaiasytaeodscsaearsdlsleieuvdmiabtydioetnshterouftecttrhimoeninm; a(yCl od)cePaoorxdsyiitunivmueclndeuoecstitlderuayrcltion; strtaainns(ifnCegr)afPsoeor-smmitieyvdoeicanatureddcilaedlaraUpsTtoPapintnoinsicigsk afoesrnadmssyelasosbceaedrlidnbigyalt(haTpeUoteNprtEmoLsiin)saalsdsaeasoysxeyasnnseuddcltbehoyettidhqeyulatetnrrtamintaisntfieavrleadseeao-nmxayleyndsuiiasctleeodoftidyl dapUoTpPttroantniiccskfneeurnacdslel-ia/mtboeetdlaiilnagnteu(dTclUediN;U(ETDLP)) aAnsinscaakylyeasnnisddotflhaBebceqllu-i2nagnatni(tdTaUtBivNaexEapLnr)aolatyessisinasyoexfapanrpedospstithooenticqbnyuuawcnlteeisit/atettriovnteabl lanonutatcillnyegsi;is of (aDnd) AtahnpeaolcypostroisrteiocsfpnBoucnlc-dl2einai/ngtodqtaBulaaxnutpictraolettiev;ine(Deax)npaArlyenssasilsiyo.snβis-baoycftwiBnecswlt-e2arsnaunbsdleodtBtianxsgtpahrneodtloetihandeiecnxogprrrceeossnpstoironondl.ibnnyg=wq6u.eas*ntpetir

IPC Activated TOPK Signaling Pathway
Discussion
Ethics Statement
In Vivo Experimental Protocols
Cell Culture and in Vitro Experimental Protocols
Determination of Myocardial Infarct Size
In-Situ Detection of Apoptosis in Heart Tissue
HE and Immunohistochemical Staining
Quantification of Cell Viability by MTS Test
Immunofluorescence Analysis
Real-Time Quantitative PCR
4.10. Western Blot Analysis
Findings
4.11. Statistical Analysis
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call